|

|
AIDS Research Alliance
621-A N. San Vicente Boulevard
Los Angeles, CA 90069 USA
Phone: 310-358-2423
Fax: 310-358-2431
E-mail:
Web: http://www.aidsresearch.org
 Provided by MapQuest
|
|
Company Overview
Founded in 1989, AIDS Research Alliance (ARA) is a non-profit
medical research organization dedicated to the discovery and
development of promising new treatments and prevention strategies
(including vaccines and microbicide) for HIV/AIDS, with a cure for
AIDS as its ultimate goal.
For many of the large HIV/AIDS drug development companies, ARA
is a leading clinical research organization with a proven track
record for extremely rapid patient enrollment (even for
hard-to-reach groups such as treatment-naïve patients and
minorities) and exceptional data collection.
As a not-for-profit organization, ARA contains study costs while
ensuring the seamless implementation of clinical studies, and is
uniquely positioned to meet the needs of HIV/AIDS drug development
companies. Speeding up study implementation, enrollment and
completion without compromising data integrity is an ARA
hallmark.
ARA is a full-service contract research organization, or CRO,
for companies engaged in HIV and AIDS-related drug development.
These services have grown to include critical-path-to-market
analysis, pre-clinical consulting and strategy, clinical protocol
design and writing, case report form (CRF) design, regulatory
affairs, data management, biostatistical design/analysis and study
report writing.
Clinical Research Experience
- Phase I-IV
- First-in-Man Studies
- Pharmacokinetics
- Drug Interaction Studies
- In-Patient Studies
- Neurological Studies
Project Management and Support Services
- Regulatory Affairs
- Pre-Clinical Development
- Study Design & Protocol Writing
- CRF Design and Development
- Data Management
- Biostatistics
Partial lists of pharmaceutical companies: Agouron
Pharmaceuticals, Pfizer, Bristol-Meyers Squibb, Gilead sciences,
Inc., GlaxoWelcome, VaxGen, Inc, Merck, Theratechnology, Tibotech,
Shaman Pharmaceuticals, Pharmacia & Upjohn, etc
Facilities
Location and Organization
ARA maintains an 8800 square foot clinical research facility
conducting clinical trials in all four Phases of drug development,
as well as development of devices, (e.g. ARA was a major site for
the development of the OraQuick HIV test with over 250 subjects
tested). The clinic site has 2 fully equipped BL-2 laboratories, 4
exam rooms, climate-controlled medication lockers and pharmacy,
20°C and -70°C freezers, temperature monitoring, and
an automatic alarm system. In addition multilingual (English,
Spanish, French) staff and HIV counseling are available.
Site Operation and Infrastructure
Data Management System
ARA uses the HIPPA compliant Study Manager? to track all patient
contacts, schedule visits within the appropriate visit window or
timeframe, to track patient participation, generate study and visit
specific checklists, and to ensure important documents for IRB
submission are submitted in a timely manner.
Regulatory
ARA maintains its own IRB (Federal Wide Assurance Number:
FWA00000941) whose sole job is to protect the rights of volunteers
in ARA protocols. In 1997, an audit of the ARA IRB by the Food and
Drug Administration (FDA) resulted in a "no findings"
report.
Laboratory Capabilities
Dr. Hezareh supervises the activity of 2 fully equipped BL-2
laboratories at ARA. Mr. Castro is responsible for the collection,
login, processing, storage and shipping of all required tests. In
addition, he processes Peripheral Blood Mononuclear cells (PBMCs)
and DNA pellets. Routine safety tests including hematology,
chemistries, urinanalysis, and serology will be sent to the UCLA
Medical Center. Because of the importance of correct timing and
handling of blood during the preparation of PBMCs and DNA pellets,
we have decided that the ARA laboratory will serve as a backup for
the UCLA CARE Clinic CRS laboratory.
Investigational Pharmacy
ARA staff is responsible for the accurate accounting, storage
and disposition of all investigational materials. Medications and
investigational materials are kept in a double locked pharmacy
room. Ambient refrigerator and freezer logs are kept for all
medications. Each year, pharmaceutical companies audit ARA pharmacy
procedures, which have been found to be consistent with Good
Clinical Practices (GCP).
Investigator Experience
Stephen J. Brown, M.D.
Medical Director
Marjan Hezareh, PhD.
Scientific Director
Seymour Young, M.D.
Neurology
Robert Winter, M.D.
Interim Associate Medical Director
Staff Expertise
Michele Vertucci, PA-C
Clinic Manager
Corie Castro
Clinical Research Assistant
Krystle Zeibell
Clinical Research Assistant
Patient Demographics
ARA has access to over 10,000 HIV+ individuals through
affiliation with community organizations and local primary care
providers. ARA maintains an in-house patient database with over
2000 well-characterized HIV positive and negative volunteers. We
endeavor to reflect both the ethnic and gender diversity of
HIV.
|
 |
 Back to
Profiles of Industry Providers
 Click here to access this Center's WWW home page.
|